speb/financial-data huggingface dataset:
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 223420000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 1970000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 359660000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 688420000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Other Special Charges: -6540000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 71640000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1277630000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 2822680000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 28340000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 28340000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Research And Development: 12030000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 13760000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1631940000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1306680000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1463460000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 32590000.00
SUMICHEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 656840000.00
SUMICHEM.NS income_statement (annual, 2022-03-31) — Write Off: 0.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 5720630000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 34733410000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 4902140000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9460620000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2256790000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2350600000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -879330000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Amortization: 28940000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 28940000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1150000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 499145736.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 10.06
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 572460000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1483380000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1198840000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 339720000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 468910000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 3084980000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -499360000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 236800000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 232110000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 490650000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 212500000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -573500000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: -268180000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -1233940000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1351660000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -103550000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 23817800000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 608450000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 22854860000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 27875480000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 162270000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 162270000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 9329980000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 489840000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 518780000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 518780000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 489840000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 499145736.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 10.06
SUMICHEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 5022090000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 9570000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — EBIT: 6580280000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — EBITDA: 7099060000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 468910000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -725450000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 4276870000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 2695010000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -166050000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 1320000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 187570000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 215530000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 10339950000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 7124950000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 11878550000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 15700000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 1320000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 38520000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 38520000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 249350000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 249350000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -15420000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 139320000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 8886970000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 23817800000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3271950000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 1150000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 992790000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 177450000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 177450000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3868980000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 20000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -1280000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income: 5022090000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 5022090000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 5022090000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 5022090000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 5022090000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 6541760000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 5022090000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: 187290000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -2215910000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 187290000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4868160000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1195360000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 23602270000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 136260000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 225630000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 371060000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 6935620000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 4896617590.50
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 3893850000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 6157920000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 34733410000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 499145736.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1261490000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 512240000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 18826340000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 215530000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 316040000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -195410000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 250000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 17600000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1645370000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 553360000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 171350000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 268800000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2616070000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -4370000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 5493450000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 63070000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 3598840000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 6541760000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 205900000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -15520320000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1198840000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 3839440000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 22854860000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 518780000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 39280000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 39280000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Research And Development: 11250000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 2559570000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1637210000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 13304410000.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 3480000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1206000000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1393570000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 499145736.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -2610000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 23817800000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 23602270000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 37967590.50
SUMICHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 1519670000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.23
SUMICHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1681090000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 33687140000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 23817800000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 339720000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 23817820000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 28575490000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 9869320000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 5811660000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 539340000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 23540000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 28380000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 163440000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 163440000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 454620000.00
SUMICHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 18545500000.00
SUMICHEM.NS income_statement (annual, 2023-03-31) — Write Off: 1290000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 5916900000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 28177670000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 4300490000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 7159130000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2335920000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 2350600000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -987600000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Amortization: 35460000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 35460000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 1150000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 499145736.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 7.40
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 468910000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1267360000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -637430000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 297430000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 466360000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 8910660000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -3098160000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 112700000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 353660000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 2817420000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 216690000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -711800000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: -634050000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 2138860000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 3899630000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -2550000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 24415670000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 60060000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 17986110000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 26728600000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 112300000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 5060000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 117360000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 8007030000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 104260000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 586430000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 621890000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 621890000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 586430000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 499145736.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 7.40
SUMICHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3695410000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 6110000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 0.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — EBIT: 5065390000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 5687280000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 466360000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -3370490000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 3512570000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 6934290000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -331320000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -2140000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 223940000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill: 622460000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 870120000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 8146730000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 7338190000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 10191560000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 2310000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 35910000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 35910000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 589970000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 589970000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -51070000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 462020000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 6104120000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 24420730000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -4203780000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1150000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 5060000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1022930000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 185130000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 185130000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 4737530000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 29750000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: -2030000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -578530000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -1320000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income: 3695410000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3695410000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3697440000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3695410000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3695410000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 5029480000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3697440000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: 533040000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -3468260000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -53480000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 533040000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -720000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 5002270000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -619010000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -53480000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 23545550000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 7440000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 236300000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 258800000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 78010000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 5498760000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 3556818855.63
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 7571720000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 4274660000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 28177670000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 499145736.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 997950000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 531840000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 590000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 247660000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 278800000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -596460000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 28400000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 31440000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1592220000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 587950000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 250310000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 414380000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 8444300000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -2140000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 4899830000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 104260000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 2771120000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 5029480000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 240980000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -578530000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -19408570000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -637430000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1968820000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 17986110000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 621890000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 50950000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 50950000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -53480000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Research And Development: 13420000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1366880000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2274640000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 15940310000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 18420000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 988470000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1212410000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 499145736.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 5060000.00
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -53480000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -142800000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 24415670000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 23545550000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 49928855.63
SUMICHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 1332040000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
SUMICHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1290430000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 33132680000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 24415670000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 302490000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 24445420000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 23903010000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 8687260000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 6404080000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 680230000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 21020000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 5280000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 188520000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 188520000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 343930000.00
SUMICHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 18721570000.00
SUMICHEM.NS income_statement (annual, 2024-03-31) — Write Off: 144940000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 4903800000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 9445000000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 71200000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 284770000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 4991460000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 530950000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 13222110000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 4991460000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 27135030000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 85130000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 31144760000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 92500000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4180000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 96680000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 10464870000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 92360000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 604410000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 862360000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 4850160000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 5642900000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 27139210000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 71200000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 192270000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 192270000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 357840000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 32160000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 4850160000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 26272670000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 16300000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 243970000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 499145736.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1115080000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 501640000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 22143570000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 257950000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 37930000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 4765030000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 1719670000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 12691160000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 5299880000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 499145736.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 27135030000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 26272670000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 38426140000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 27135030000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 288950000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 27167190000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 11258950000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 7281380000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 794080000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 396080000.00
SUMICHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 20679890000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1834890000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 6419190000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 499712644.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.74
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 3713760000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 190640000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 190640000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 499712644.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.74
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — EBIT: 1182880000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — EBITDA: 1373520000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 2705430000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 17870000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 17870000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -4800000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 874300000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 874300000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -17870000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -17870000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1373520000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 869500000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Operating Income: 870540000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 6419190000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 312340000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 960810000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1165010000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 3713760000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 190640000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 290710000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 5548650000.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
SUMICHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 6683140000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1688120000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 31189870000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 6794210000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 4893660000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4893660000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 7833680000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7833680000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2796420000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2796420000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2350600000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2350600000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1000880000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1000880000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Amortization: 30060000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 30060000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 637600000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 637600000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 499145736.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 497920000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 10.13
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 466360000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1591310000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1591310000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -294550000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 518930000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 518930000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 4991460000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 382330000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 382330000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 12593760000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 12593760000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -440280000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 148500000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 148500000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 233830000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 233830000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -938330000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -129780000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 923590000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 594160000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -692520000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -180460000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -84030000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 4991460000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 4991460000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 29011450000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 29011450000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 133360000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 133360000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 18832800000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4074630000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 30203040000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 30203040000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 191120000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 191120000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 191120000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 191120000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 9651780000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9651780000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 90170000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 90170000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 630520000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 660580000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 660580000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 164160000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 630520000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 164160000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 499145736.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 497920000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 10.13
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 5054960000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 995840000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 15060000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 15060000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 10000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — EBIT: 6849380000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 1347660000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 7509960000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1511820000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 382330000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 667760000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 667760000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -679200000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 3927130000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3927130000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 4220490000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -364900000.00
SUMICHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 800000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 264080000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill: 604410000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 604410000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 862260000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 862260000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 8834560000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 8834560000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 7822250000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 7822250000.00
SUMICHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 12357070000.00
SUMICHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2719580000.00
SUMICHEM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 22030000.00
SUMICHEM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 22030000.00